In addition, a study performed in a murine AT3 breast cancer model shows that combined radiotherapy and anti-CD137 treatment upregulated the expression of CD137 on tumor-specific CD8+ CTLs [42]. This evidence concerns the gene TNFRSF9 and breast cancer.